Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Feb 27, 2014

30339_dirs_2014-02-27_c78d4f74-fe32-41d0-a449-0ca2fae4abc5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-02-26

Reporting Person: ZENNER PATRICK J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-26 Common Stock M 12800.0000 $9.6825 Acquired 54321.7300 Direct
2014-02-26 Common Stock S 12800.0000 $46.1223 Disposed 41521.7300 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-26 Stock Option (Right to Buy) $9.6825 M 12800.0000 Disposed 2015-05-05 Common Stock (12800.0000) Direct